Condition
Cutibacterium Acnes
Total Trials
6
Recruiting
2
Active
2
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
33%
2 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
P 4 (2)
Trial Status
Completed2
Recruiting2
Unknown1
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT07731802Phase 4Not Yet Recruiting
Finasteride and Cutibacterium
NCT06513182Not ApplicableCompletedPrimary
Do Wound Protectors Reduce Contamination in Total Shoulder Arthroplasty?
NCT07406893Not ApplicableRecruiting
Reduction of Bacterial Seeding in Total Shoulder Arthroplasty
NCT07085247Recruiting
The Role of Cutibacterium Acnes in the Development of Degenerative Lumbar Intervertebral Disc Disease
NCT05919888Phase 4Completed
SURGX Antimicrobial Gel Versus Povidone-iodine Skin Incision Prep in Total Shoulder Arthroplasty
NCT03950063Unknown
Cutibacterium Acnes in Bone and Joint Infections
Showing all 6 trials